Business Development Manager

Responsibilities

• Analyze therapeutic areas, unmet medical needs, and competitor pipelines to prioritize BD opportunities.
• Monitor patent landscapes, clinical trial developments, and regulatory trends.
• Support end-to-end transactions (licensing, co-development, M&A) from target identification to term sheet negotiation.
• Model financial scenarios (NPV, ROI) for potential partnerships using industry benchmarks.
• Partner with R&D to assess scientific feasibility of in-licensing candidates.
• Work with legal/IP teams to draft confidentiality agreements and due diligence frameworks.
• Prepare investor-ready materials and pitch decks for potential partners.
• Present recommendations to senior leadership with data-driven rationale.

Qualifications

• MBA, with a concentration in healthcare management, life sciences, or business strategy preferred
• Prior exposure to pharmaceutical business development via internships, consulting projects, or academic collaborations.
• Familiarity with industry databases (e.g., Cortellis, Citeline, Evaluate Pharma) and CRM platforms (e.g., Salesforce).
• Demonstrated proficiency in financial valuation techniques (DCF, rNPV, comparables analysis) and partnership modeling, with the ability to assess scientific, commercial, and regulatory risks.
• Comprehensive understanding of pharmaceutical intellectual property landscapes, licensing frameworks, and global regulatory pathways (FDA/EMA/ICH guidelines).
• Superior ability to synthesize complex scientific and commercial data into actionable business insights for executive stakeholders.
• Proven track record of crafting persuasive, data-driven narratives for partnerships, investor communications, or internal governance reviews.
• Exceptional negotiation acumen, with experience supporting term sheet development or due diligence processes (even in academic/internship settings).
• Intellectual curiosity about emerging science, with the ability to rapidly evaluate therapeutic-area opportunities (e.g., oncology, rare diseases, CNS).
• Collaborative mindset to bridge cross-functional gaps between R&D, legal, and commercial teams.